NCT03898466
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Asthma Research Lab University of Saskatchewan Room 346 Ellis Hall Saskatoon, Saskatchewan, Canada
Clinical trial condition
Hypersensitivity, Immediate
Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.
6,751 public trials
635 recruiting studies
Hypersensitivity, Immediate trial results
NCT03349060
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
- Locations
-
- Clinical Research Center of Alabama, LLC Birmingham, Alabama, United States
- California Dermatology & Clinical Research Institute Encinitas, California, United States
- Rady Children's Hospital - San Diego/University of California, San Diego San Diego, California, United States
- TCR Medical Corporation San Diego, California, United States
NCT03349619
- Conditions
- Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
- Locations
-
- Institute of Biomedicine and Molecular Immunology (IBIM) - National Research Council of Palermo Palermo, Italy
Completed
Leukocyte Function in Asthma and COPD
NCT00147069
- Conditions
- Asthma, Bronchial Diseases, Bronchitis, +18 more
- Locations
-
- Royal Brompton Hospital/NHLI Imperial College London London, United Kingdom
NCT02005627
- Conditions
- Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +8 more
- Locations
-
- NHS Royal Brompton Hospital London, United Kingdom
NCT00739921
- Conditions
- Allergic Fungal Sinusitis, Bacterial Infections and Mycoses, Hypersensitivity, +15 more
- Locations
-
- University of California, San Francisco, Dept of Otolaryngology-HNS San Francisco, California, United States
Completed
Asthma and Obstructive Sleep Apnea (OSA)
NCT01026298
- Conditions
- Apnea, Asthma, Bronchial Diseases, +15 more
- Locations
-
- Univeristy of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
Completed
Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children
NCT02377427
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +12 more
- Locations
-
- GSK Investigational Site San Diego, California, United States
- GSK Investigational Site Oklahoma City, Oklahoma, United States
- GSK Investigational Site Medford, Oregon, United States
- GSK Investigational Site Madison, Wisconsin, United States
NCT02660853
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Biomedical research Unit, Royal Brompton Hospital, Sydney Street London, United Kingdom
NCT03014674
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Baltimore, Maryland, United States
- GSK Investigational Site Berlin, Germany
- GSK Investigational Site Harrow, Middlesex, United Kingdom